Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. A dad’s story: How adopting my daughter from China changed my life
Sneed and his daughter, Karis
Sneed and his daughter, Karis

A dad’s story: How adopting my daughter from China changed my life

Sneed and his daughter, Karis

A whirlwind of emotions. That’s what Michael Sneed felt when he brought his daughter, Karis, home from an adoption center in China.

“That first night, [I remember] having it all hit me and going, ‘Wow, this is our child,’ ” he recalls.

Sneed, Executive Vice President, Global Corporate Affairs & Chief Communication Officer at Johnson & Johnson, adopted then 15-month-old Karis from a Hong Kong orphanage in 2002. At the time, he had been traveling to China quite frequently for work when he proposed the idea of adopting a baby from the country to his wife, Ann Sneed.

The couple already had two children—a daughter named Taylor and a son, Logan—and as Sneed recalls, “We felt it was right. It felt good for us as a family.”

Johnson & Johnson has a long history of caring for employees—and their families. Recently, the company announced enhancements to its family benefits in the U.S., including surrogacy assistance and adoption assistance, so employees like Sneed can fulfill their dreams of building a family.

“It’s industry-leading in terms of the vision and the impact of the support that we provide for the people of Johnson & Johnson,” Sneed says.

As you will see in this video chronicling Sneed’s journey as an adoptive parent, a loving and nurturing family can take all shapes and forms.

“Family’s about extended love,” Ann Sneed says. “And whether it’s biological or adopted, it’s really supporting these children, helping them grow, building a legacy.”

More from Johnson & Johnson

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.